Keywords
How to Cite
Abstract
Combatting neonatal infections requires a comprehensive approach that encompasses early diagnosis, innovative therapies, and prevention strategies. Early diagnosis plays a crucial role in the immediate identification of infections in newborns, enabling rapid and effective interventions to avoid serious complications. This is particularly important due to the vulnerability of babies to these infections because of their still-developing immune systems. Moreover, prompt diagnosis allows for the implementation of specific therapies targeted at the infectious agents, contributing to better prognoses and outcomes for newborns.
Innovative therapies are continuously being developed to combat neonatal infections. Advances in medications, surgical techniques, and medical technologies are expanding the array of treatments available to healthcare professionals. This includes the development of more effective and safer drugs, as well as the application of minimally invasive techniques for treating complications associated with these infections. Additionally, research in innovative therapies seeks more personalized and targeted approaches, taking into account the individual characteristics of each baby and the infectious agent involved.
In parallel with therapies, prevention strategies play a fundamental role in reducing the incidence of neonatal infections. This includes measures such as promoting breastfeeding, which provides passive immunity to newborns, and implementing strict hygiene protocols in neonatal units to prevent the transmission of infectious agents. Furthermore, the prudent use of antibiotics and active surveillance to detect and early treat possible infection foci are essential components of prevention strategies.
In summary, effective combatting of neonatal infections requires a multifaceted approach involving early diagnosis, innovative therapies, and prevention strategies. These integrated approaches have the potential to significantly reduce the morbidity and mortality associated with these infections, ensuring a healthy and promising start for newborns.
References
ABOUELKHEIR, Manal et al. Evaluation of vancomycin individualized model-based dosing approach in neonates. Pediatrics and Neonatology, v. 64, p. 327-334, 2023.
BALSAMO, Felicia et al. Argon inhalation attenuates systemic inflammation and rescues lung architecture during experimental neonatal sepsis. Pediatric Surgery International, v. 40, p. 21, 2024.
BOSCARINO, Giovanni et al. An overview of antibiotic therapy for early- and late-onset neonatal sepsis: Current strategies and future prospects. Antibiotics, v. 13, p. 250, 2024.
DALUT, Laurie et al. Early-onset neonatal sepsis: Effectiveness of classification based on ante and intrapartum risk factors and clinical monitoring. Journal of Gynecology Obstetrics and Human Reproduction, v. 53, p. 102775, 2024.
FOURGEAUD, Jacques et al. Predictors of the outcome at 2 years in neonates with congenital cytomegalovirus infection. Pediatrics, v. 153, n. 4, e2023063531, abril 2024.
FRANÇA, Angela. The role of coagulase-negative Staphylococci biofilms on late-onset sepsis: Current challenges and emerging diagnostics and therapies. Antibiotics, v. 12, p. 554, 2023.
GORDÓN PIDAL, José M. et al. Micromotor based dual aptassay for early cost effective diagnosis of neonatal sepsis. Microchimica Acta, v. 191, p. 106, 2024.
LERUEZ-VILLE, Marianne et al. Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI). The Lancet Regional Health - Europe, v. 40, p. 100892, 2024.
PAPACHATZI, Eleni et al. Daptomycin use for persistent coagulase-negative staphylococcal bacteremia in a neonatal intensive care unit. Antibiotics, v. 13, p. 254, 2024.
WU, Yue-E et al. Carbapenem-resistant Enterobacteriaceae bloodstream infection treated successfully with high-dose meropenem in a preterm neonate. Frontiers in Pharmacology, v. 11, article 566060, 2020.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Matheus Fakhri Kadan , Bibiana Carneiro Monteiro Nunes , Eduardo Alfredo Caldas Queruz , Andressa Luise Matte, Khaled Walid Rahal
